Nuvectis Pharma Inc
Nuvectis Pharma Inc (NVCT) Covered Calls
Loading NVCT covered call opportunities from the prior session (coming three months window)…
Read more
Running NVCT covered calls helps you generate consistent income from Nuvectis Pharma Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Nuvectis Pharma Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best NVCT covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if NVCT stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling NVCT covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Nuvectis Pharma Inc covered call is worth writing.
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.
Income-focused investors, long-term NVCT holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling NVCT covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Nuvectis Pharma Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile15.48% Subdued
- Market cap (M$)660
- 52 weeks high-30.94%
- 52 weeks low264.32%
- Analyst recommendationStrong Buy
1.00 - Target price$35.40
75.07% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-03
- P/E—
- Future P/E—
- EPS (ttm)-1.28
- EPS growth next 5 years2.54%
As of September 25, 2026
No illustrative rows to display.
As of September 25, 2026
Sell covered calls with the data behind you
Find the best NVCT covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→